Document is current
Any future updates will be listed below
-
Authors
Megquier, Kate https://orcid.org/0000-0002-1458-0865
Husted, Christopher
Rhoades, Justin
White, Michelle E.
Genereux, Diane P.
Chen, Frances L.
Xiong, Kan
Kwon, Euijin
Swofford, Ross https://orcid.org/0000-0003-3676-8479
Painter, Corrie
Adalsteinsson, Viktor A. https://orcid.org/0000-0003-4555-2485
London, Cheryl A.
Gardner, Heather L. https://orcid.org/0000-0001-6007-6144
Karlsson, Elinor K. https://orcid.org/0000-0002-4343-3776
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 21 April 2026
First Online: 11 June 2026
Competing interests
: E.K.K., C.A.L., and C.P. are members of The One Health Company advisory board. C.A.L. is an advisor to Merck Animal Health. C.P. is an employee of Precede Biosciences. K.M., R.S., V.A.A., C.A.L., H.L.G., and E.K.K. are contributors to the canine exome panel described in this work. The Broad Institute has licensed certain rights related to the canine exome panel, and K.M., R.S., V.A.A. and E.K.K. may receive licensing revenue from the Broad Institute in accordance with its licensing revenue sharing policy. V.A.A. is a co-inventor of the MAESTRO MRD test which has been licensed to Exact Sciences and is a co-founder and advisor to Amplifyer Bio. V.A.A. is also a co-inventor on patent applications filed by the Broad Institute on cfDNA sequencing methods utilized in this manuscript. All other authors declare no competing interest.
